Ligand validation:6DGZ

A60: (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-ethylbutyl)amino}-1-benzyl-2-hydroxypropyl]carbamate

A60 is a Ligand Of Interest in 6DGZ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6DGZ_A60_A_102	67%	2%	0.146	0.955	5.42	2.09	26	11	0	0	100%	1
3O9E_A60_A_200	98%	26%	0.057	0.979	1.72	1.45	3	9	0	0	100%	1
6DH2_A60_A_102	68%	2%	0.144	0.957	5.37	2.14	26	12	0	0	100%	1
6DH8_A60_A_105	66%	1%	0.141	0.948	5.54	2	27	11	0	0	100%	1
6DH5_A60_A_104	55%	1%	0.165	0.936	5.67	2.31	28	11	0	0	100%	1
6W6R_A60_A_201	42%	1%	0.174	0.895	5.8	3.03	30	24	4	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.